The risk of long COVID was two to three times higher after the initial infection (14.8%) than after first (5.8%) or second (5.3%) reinfections.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Except for a slight decrease from Mar 29 to Apr 11, 2020, emergency department (ED) visits involving drug and opioid overdoses (ODs) were 1% to 45% more frequent than in 2019, according to a JAMA Psychiatry study published yesterday.
People age 35 to 49 have especially contributed to recent outbreaks.
Findings suggest the vaccine provides strong protection after 1 dose and could slow disease spread.
Though US numbers have fallen, the CDC head warns they are overall still very high.
Higher viral loads of SARS-CoV-2, the virus that causes COVID-19, are associated with an increased risk of transmission, according to cohort study results from Catalonia, Spain, published yesterday in The Lancet Infectious Diseases,
CARB-X announced today that it is awarding up to $6.4 million to French biopharmaceutical firm Mutabilis to develop a new class of antibiotics to treat infections caused by carbapenem-resistant Enterobacterales (CRE) bacteria.
Also, vaccine doses sent to states will rise from 10 million to 10.5 million.
Researchers find some B117 variants with the E484K mutation tied to vaccine resistance, and data raise red flags about vaccine protection.
"Another vaccine can now join the fight to reduce the incidence of COVID-19."
CDC researchers recommend improving racial data tracking and health workers' uptake.
